2.31
price down icon0.86%   -0.02
after-market After Hours: 2.29 -0.02 -0.87%
loading
Psychemedics Corp stock is traded at $2.31, with a volume of 65,198. It is down -0.86% in the last 24 hours and up +0.43% over the past month. Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.
See More
Previous Close:
$2.33
Open:
$2.31
24h Volume:
65,198
Relative Volume:
2.03
Market Cap:
$13.45M
Revenue:
$22.10M
Net Income/Loss:
$-4.15M
P/E Ratio:
-6.7722
EPS:
-0.3411
Net Cash Flow:
$-1.64M
1W Performance:
+0.43%
1M Performance:
+0.43%
6M Performance:
-21.16%
1Y Performance:
-41.81%
1-Day Range:
Value
$2.2901
$2.33
1-Week Range:
Value
$2.2901
$2.345
52-Week Range:
Value
$1.63
$3.97

Psychemedics Corp Stock (PMD) Company Profile

Name
Name
Psychemedics Corp
Name
Phone
978-206-8220
Name
Address
125 NAGOG PARK, ACTON, MA
Name
Employee
116
Name
Twitter
@hairdrugtest
Name
Next Earnings Date
2024-09-02
Name
Latest SEC Filings
Name
PMD's Discussions on Twitter

Psychemedics Corp Stock (PMD) Latest News

pulisher
Sep 26, 2024

Psychemedics Releases First-Ever Education Insights Report: Uncovering Drug Trends in Educational Institutions Through Hair Testing - Yahoo Finance

Sep 26, 2024
pulisher
Sep 25, 2024

Survey: Mental health professionals largely open to psychedelic treatments – if legal - Green Market Report

Sep 25, 2024
pulisher
Sep 25, 2024

474% return in 1 year: PC Jeweller shares hit fresh 52-week high as board to consider stock split - MSN

Sep 25, 2024
pulisher
Sep 25, 2024

PC Jeweller's first share split announced: 180 percent multibagger gain in just 3 months - India.com

Sep 25, 2024
pulisher
Sep 25, 2024

PC Jeweller Soars 452%! Big News Ahead as Company Plans First-Ever Stock Split on September 30 - Share Price India News

Sep 25, 2024
pulisher
Sep 25, 2024

At 52-week high! Multibagger stock PC Jeweller to declare stock split after 452% surge in one year - MSN

Sep 25, 2024
pulisher
Sep 25, 2024

This jewellery stock hits 52-week high as board to consider stock split; check details - Upstox

Sep 25, 2024
pulisher
Sep 25, 2024

PC Jewellers shares rise 4% on considering stock split in upcoming board meeting - The Economic Times

Sep 25, 2024
pulisher
Sep 25, 2024

PC Jeweller shares hit 52-week high ahead of board meeting to consider stock split - Business Upturn

Sep 25, 2024
pulisher
Sep 25, 2024

PC Jeweller hits 52-wk high as board to consider stock split on Sept 30 - Business Standard

Sep 25, 2024
pulisher
Sep 24, 2024

At 52-week high! Multibagger stock PC Jeweller to declare stock split after 452% surge in one year | Stock Market News - Mint

Sep 24, 2024
pulisher
Sep 24, 2024

PC Jeweller shares in news today as board to consider stock split - Business Today

Sep 24, 2024
pulisher
Sep 24, 2024

ProMIS Neurosciences, Inc. (NASDAQ:PMN) Director Buys $89,600.00 in Stock - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Director Madge Shafmaster Acquires 200,000 Shares of ProMIS Neur - GuruFocus.com

Sep 24, 2024
pulisher
Sep 24, 2024

Psyence Group offloads PsyLabs stake to spinoff - Green Market Report

Sep 24, 2024
pulisher
Sep 24, 2024

PC Jeweller to consider stock split on September 30 - CNBCTV18

Sep 24, 2024
pulisher
Sep 24, 2024

Epineuron Announces Health Canada Approval of the PeriPulse™ System for Nerve Regeneration - Business Wire

Sep 24, 2024
pulisher
Sep 24, 2024

Popular Foundations Shares Underperform At Market Debut - Knn India

Sep 24, 2024
pulisher
Sep 24, 2024

Popular Foundations shares make tepid debut on BSE SME, list flat at ₹37 | Stock Market News - Mint

Sep 24, 2024
pulisher
Sep 24, 2024

BSE SME Popular Foundation slips on debut - Business Standard

Sep 24, 2024
pulisher
Sep 24, 2024

Popular Foundations shares list at IPO price on BSE SME platform - The Economic Times

Sep 24, 2024
pulisher
Sep 24, 2024

Popular Foundations makes tepid debut, shares list flat at ₹37 apiece on BSE SME platform - Upstox

Sep 24, 2024
pulisher
Sep 24, 2024

Popular Foundations share price hits lower circuit post listing, falls 5% from IPO price - Moneycontrol

Sep 24, 2024
pulisher
Sep 23, 2024

Recent Insider Activity Could Benefit Personalis Inc (PSNL) - Knox Daily

Sep 23, 2024
pulisher
Sep 23, 2024

Small Cap Stocks: Plexus, Parkmead, Proton Motor - The Armchair Trader

Sep 23, 2024
pulisher
Sep 23, 2024

LIC-backed multibagger stock under Rs 150 is locked in the upper circuit on September 23; Stock gained 475 per cent from its 52-week low - Dalal Street Investment Journal

Sep 23, 2024
pulisher
Sep 23, 2024

Psp Projects shares surge 3% after receiving orders worth Rs 554.92 crore - Business Upturn

Sep 23, 2024
pulisher
Sep 21, 2024

2 ASX shares I can’t ignore: PME and SOL - Rask Media

Sep 21, 2024
pulisher
Sep 19, 2024

Should PME shares be on your watchlist? - Rask Media

Sep 19, 2024
pulisher
Sep 19, 2024

Insider Buying: Tempus AI, Inc., Personalis Inc [PSNL] 10% Owner invested 3,500,000 shares - Knox Daily

Sep 19, 2024
pulisher
Aug 29, 2024

Psychemedics Corporation Launches New Ketamine Hair Testing Service - Yahoo Finance

Aug 29, 2024
pulisher
Aug 14, 2024

PMD Stock Earnings: Psychemedics Reported Results for Q2 2024 - MSN

Aug 14, 2024
pulisher
Aug 14, 2024

Psychemedics: Q2 Earnings Snapshot - San Antonio Express-News

Aug 14, 2024
pulisher
Aug 13, 2024

Psychemedics: Q2 Earnings Snapshot - San Francisco Chronicle

Aug 13, 2024
pulisher
Aug 13, 2024

Psychemedics: Q2 Earnings Snapshot - Weatherford Democrat

Aug 13, 2024
pulisher
Aug 13, 2024

Psychemedics (PMD) Strategic Move Spurs Share Price Increase - Stocks Telegraph

Aug 13, 2024
pulisher
Aug 13, 2024

Psychemedics Corporation Reports Second Quarter 2024 Financial Results - Yahoo Finance

Aug 13, 2024
pulisher
Aug 12, 2024

Psychemedics to delist from Nasdaq after reverse stock split - Investing.com

Aug 12, 2024
pulisher
Aug 12, 2024

Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock - Yahoo Finance

Aug 12, 2024
pulisher
Aug 12, 2024

Psychemedics Corporation’s Board of Directors Approves Plan to Terminate Registration of Its Common Stock - GlobeNewswire

Aug 12, 2024
pulisher
Aug 08, 2024

Psychemedics stock plunges to 52-week low at $1.66 - Investing.com

Aug 08, 2024
pulisher
Jul 27, 2024

Psychemedics stock hits 52-week low at $2.05 amid challenges - Investing.com India

Jul 27, 2024
pulisher
Jul 26, 2024

Psychemedics stock hits 52-week low at $2.05 amid challenges - Investing.com

Jul 26, 2024
pulisher
Jun 25, 2024

Psychemedics Corp (NASDAQ:PMD)Research - Intelligent Investor

Jun 25, 2024
pulisher
Jun 21, 2024

After Moving HQ to Dallas, Psychemedics Releases Report on Drug Trends in the U.S. Workplace - dallasinnovates.com

Jun 21, 2024
pulisher
Jun 21, 2024

Psychemedics Unveils Inaugural Insights Report: Revealing Drug Trends Through Hair Testing - Yahoo Finance

Jun 21, 2024
pulisher
Jun 11, 2024

One Psychemedics Corporation (NASDAQ:PMD) insider upped their stake by 13% in the previous year - Yahoo New Zealand News

Jun 11, 2024
pulisher
Jun 07, 2024

Psychemedics (NASDAQ:PMD) and BioNexus Gene Lab (NASDAQ:BGLC) Head to Head Analysis - Defense World

Jun 07, 2024
pulisher
Jun 05, 2024

Insiders Sold Psychemedics At US$4.66, Meanwhile Stock Sits Near US$2.32 - Simply Wall St

Jun 05, 2024
pulisher
Jun 03, 2024

NASDAQ 100 Over 6% Up In The Last 21 Sessions - Via News Agency

Jun 03, 2024
pulisher
Jun 03, 2024

Psychemedics Optimizes Costs with Early Lease TerminationTipRanks.com - TipRanks

Jun 03, 2024

Psychemedics Corp Stock (PMD) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$223.48
price up icon 0.62%
$130.41
price up icon 0.22%
diagnostics_research WAT
$359.89
price up icon 0.72%
$287.31
price up icon 0.60%
diagnostics_research MTD
$1,499.70
price up icon 1.41%
$505.22
price down icon 1.28%
Cap:     |  Volume (24h):